143 related articles for article (PubMed ID: 1699285)
1. Fludarabine phosphate therapy in other lymphoid malignancies.
Kantarjian HM; Redman JR; Keating MJ
Semin Oncol; 1990 Oct; 17(5 Suppl 8):66-70. PubMed ID: 1699285
[TBL] [Abstract][Full Text] [Related]
2. [The use of fludarabine phosphate (Fludara) to treat chronic B-cell lymphocytic leukemia and non-Hodgkin's lymphoma resistant to standard chemotherapy].
Gershanovich ML; Zaritskiĭ AIu; Medvedeva NV; Abdulkadyrov KM; Samuskevich IG; Beresneva IA
Vopr Onkol; 1998; 44(6):696-700. PubMed ID: 10087967
[TBL] [Abstract][Full Text] [Related]
3. Fludarabine phosphate. A new anticancer drug with significant activity in patients with chronic lymphocytic leukemia and in patients with lymphoma.
Rodriguez G
Invest New Drugs; 1994; 12(2):75-92. PubMed ID: 7532163
[TBL] [Abstract][Full Text] [Related]
4. Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies.
Chun HG; Leyland-Jones B; Cheson BD
J Clin Oncol; 1991 Jan; 9(1):175-88. PubMed ID: 1702143
[TBL] [Abstract][Full Text] [Related]
5. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia.
Keating MJ
Semin Oncol; 1990 Oct; 17(5 Suppl 8):49-62. PubMed ID: 1699283
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive phase I and II clinical investigation of fludarabine phosphate.
Grever M; Leiby J; Kraut E; Metz E; Neidhart J; Balcerzak S; Malspeis L
Semin Oncol; 1990 Oct; 17(5 Suppl 8):39-48. PubMed ID: 1699282
[TBL] [Abstract][Full Text] [Related]
7. Fludarabine phosphate: an effective therapy for lymphoid malignancies.
Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-78. PubMed ID: 1699278
[No Abstract] [Full Text] [Related]
8. Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.
Binet JL
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):5-7. PubMed ID: 7685518
[TBL] [Abstract][Full Text] [Related]
9. Issues for the future development of fludarabine phosphate.
Cheson BD
Semin Oncol; 1990 Oct; 17(5 Suppl 8):71-8. PubMed ID: 1699286
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of oral fludarabine phosphate in relapsed indolent B-Cell non-Hodgkin's lymphoma.
Tobinai K; Watanabe T; Ogura M; Morishima Y; Ogawa Y; Ishizawa K; Minami H; Utsunomiya A; Taniwaki M; Terauchi T; Nawano S; Matsusako M; Matsuno Y; Nakamura S; Mori S; Ohashi Y; Hayashi M; Seriu T; Hotta T
J Clin Oncol; 2006 Jan; 24(1):174-80. PubMed ID: 16330664
[TBL] [Abstract][Full Text] [Related]
11. Phase I clinical trials with fludarabine phosphate.
Von Hoff DD
Semin Oncol; 1990 Oct; 17(5 Suppl 8):33-8. PubMed ID: 1699281
[TBL] [Abstract][Full Text] [Related]
12. Fludarabine phosphate therapy of non-Hodgkin's lymphoma.
Hochster H; Cassileth P
Semin Oncol; 1990 Oct; 17(5 Suppl 8):63-5. PubMed ID: 1699284
[TBL] [Abstract][Full Text] [Related]
13. New initiatives with fludarabine monophosphate in hematologic malignancies.
Keating MJ; O'Brien S; Robertson LE; Kantarjian H; Dimopoulos M; McLaughlin P; Cabanillas F; Gregoire V; Yang LY; Gandhi V
Semin Oncol; 1993 Oct; 20(5 Suppl 7):13-20. PubMed ID: 7694371
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
Rossi JF; van Hoof A; de Boeck K; Johnson SA; Bron D; Foussard C; Lister TA; Berthou C; Kramer MH; Littlewood TJ; Marcus RE; Deconinck E; Montillo M; Guibon O; Tollerfield SM
J Clin Oncol; 2004 Apr; 22(7):1260-7. PubMed ID: 15051774
[TBL] [Abstract][Full Text] [Related]
15. Fludarabine phosphate in lymphoma: an important new therapeutic agent.
McLaughlin P; Robertson LE; Keating MJ
Cancer Treat Res; 1996; 85():3-14. PubMed ID: 9043771
[No Abstract] [Full Text] [Related]
16. Fludarabine phosphate--looking forward.
Cheson BD
Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-2. PubMed ID: 1699277
[No Abstract] [Full Text] [Related]
17. Fludarabine shows promise for some leukemia patients.
Oncology (Williston Park); 1989 Mar; 3(3):14. PubMed ID: 2484283
[No Abstract] [Full Text] [Related]
18. [Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma].
Arima N; Mizoguchi H; Shirakawa S; Tomonaga M; Takatsuki K; Ohno R
Gan To Kagaku Ryoho; 1999 Apr; 26(5):619-29. PubMed ID: 10234292
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary toxicity associated with fludarabine monophosphate.
Hurst PG; Habib MP; Garewal H; Bluestein M; Paquin M; Greenberg BR
Invest New Drugs; 1987; 5(2):207-10. PubMed ID: 2443463
[TBL] [Abstract][Full Text] [Related]
20. Fludarabine therapy in macroglobulinemic lymphoma.
Kantarjian HM; Alexanian R; Koller CA; Kurzrock R; Keating MJ
Blood; 1990 May; 75(10):1928-31. PubMed ID: 1692487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]